|
CN102764280A
|
|
Bezoar and musk containing pharmaceutical composition and its application
|
|
CN102526058A
|
|
Anti-inflammatory analgesic medicinal composition containing lornoxicam and esomeprazole
|
|
CN102525953A
|
|
Tanshinone IIA acrylic acid injection and preparation method thereof
|
|
CN102382121A
|
|
Ginkgolide derivative and application thereof to pharmacy
|
|
CN102232981A
|
|
Determination method of content of radix serratulae total sterone
|
|
CN102210696A
|
|
Pharmaceutical composition containing zoledronic acid
|
|
CN102190664A
|
|
Bilobalide B hydrolyzed derivatives and application thereof
|
|
CN101967153A
|
|
Metabolite of 10-O-(dimethylamino ethyl) ginkgolides B and medicinal composition containing same
|
|
CN101570564A
|
|
Method for refining tanshinone II A acrylic acid
|
|
CN101712655A
|
|
Acetamide derivative and application thereof in pharmacy
|
|
CN101685085A
|
|
Method for analyzing high performance liquid chromatography of methanesulfonic amine ginkgolide B
|
|
CN101675925A
|
|
Dimethylaminoethyl ginkgolide B mesylate injection and preparation method thereof
|
|
CN101284810A
|
|
Cyano-pyrrolidine and cyano-tetrahydrothiazole derivates
|
|
CN101307076A
|
|
Prodrug with liver-targeted anti-HBV effect
|
|
CN101186610A
|
|
Methylsulfonic acid 10-O-(dimethyl amido ethyl) Ginkgolide B semihydrate crystal and preparation method thereof
|
|
CN101323621A
|
|
Synthetic technological process of bilobalide B derivates
|
|
CN101302221A
|
|
Anti-platelet activating factor compound
|
|
CN1915218A
|
|
Sodium sulfonate injection of tanshinone IIA, and preparation method
|
|
CN1837213A
|
|
Bilobalide A derivatives and pharmaceutical application thereof
|
|
CN1837198A
|
|
Tanshinone IIA derivatives and pharmaceutical application thereof
|
